<ORGANIZATION>Quest Biotechnology Inc</ORGANIZATION> said its new subsidiary , <ORGANIZATION>Quest Blood Substitute Inc</ORGANIZATION> , signed the agreement and plan of merger with <ORGANIZATION>Hunt Research Corp</ORGANIZATION> and its affiliate , <ORGANIZATION>ICAS Corp.</ORGANIZATION> .
It said <ORGANIZATION>Quest Blood</ORGANIZATION> expects to complete the merger within the next several weeks .
Terms were not disclosed .
In a related transaction , <ORGANIZATION>Quest Blood</ORGANIZATION> said it executed an agreement with <ORGANIZATION>Alza Corp</ORGANIZATION> , which will make <ORGANIZATION>Alza</ORGANIZATION> a preferred shareholder of <ORGANIZATION>Quest Blood</ORGANIZATION> and offer <ORGANIZATION>Alza</ORGANIZATION> the right to acquire a total equity position of up to 25 pct of <ORGANIZATION>Quest Blood</ORGANIZATION> in exchange for acquisition of patent rights to <ORGANIZATION>Alza</ORGANIZATION> technology .
